SCHEMBL13259059

SCHEMBL13259059

COc1cc(C(C)(C)c2cnc(CNc3c(F)cccc3Cl)n2-c2ccc(F)cc2)ccc1C(C)O

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 20/20 0.52
NR1H4 Q96RI1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL604323 0.90 GPBAR1 (0.64) GPBAR1NR1H4
SCHEMBL13259120 0.89 GPBAR1 (0.57) GPBAR1NR1H4
SCHEMBL13259939 0.87 GPBAR1 (0.46) GPBAR1NR1H4
SCHEMBL13259055 0.87 GPBAR1 (0.45) GPBAR1NR1H4
SCHEMBL13259101 0.86 GPBAR1 (0.54) GPBAR1NR1H4
SCHEMBL13259940 0.86 GPBAR1 (0.45) GPBAR1NR1H4
SCHEMBL13259918 0.85 GPBAR1 (0.58) GPBAR1NR1H4
SCHEMBL13259082 0.84 GPBAR1 (0.50) GPBAR1
SCHEMBL13259268 0.84 GPBAR1 (0.52) GPBAR1NR1H4
SCHEMBL13259104 0.83 GPBAR1 (0.45) GPBAR1NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010093845-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY EXELIXIS, INC. (US) 2010-08-19 WO disclosed